Photo via Reason

Senators Want To Tell the Drug Police How To Practice Medicine

Read the original at Reason ↗
Cite

Singer, J. A. (2026, November 20). Senators Want To Tell the Drug Police How To Practice Medicine. Reason. https://reason.com/2026/11/20/senators-want-to-tell-the-drug-police-how-to-practice-medicine/

Dated from the outlet's own feed. Check the original for its byline.

Reason · collected 2026-11-20 · by Jeffrey A. Singer

Quick Summary

Eight U.S. senators have written to the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) urging them to reconsider recent policy changes regarding kratom, a plant used for pain management and opioid withdrawal. The senators argue that kratom is an opioid, despite the DEA proposing to adjust concentration limits for certain compounds in kratom before finalizing new regulations. The DEA's October proposal would classify solid products containing more than 0.1 percent of 7-hydroxymitragynine (7-OH) or mitragynine pseudoindoxyl (MP) by weight as Schedule I substances, but this proposal has not yet been implemented.
Written by AI on 2026-11-22, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Senators Charles Grassley and seven others recently wrote a letter to the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA), urging the DEA to reinstate and enforce a limit on the concentration of 7-hydroxymitragynine (7-OH) and mitragynine (MP) in kratom products. The senators want solid products containing more than 0.1 percent of these compounds to be classified under Schedule I, despite the DEA previously proposing but not implementing this change. The senators argue that kratom is an opioid, but critics point out that not all kratom products are alike, and the compounds in question are present in trace amounts in natural kratom leaves. A review from the Reason Foundation highlights how many people use kratom to manage pain and ease opioid withdrawal, and military veterans have described using concentrated 7-OH to treat pain and PTSD symptoms, reducing their reliance on other opioids or alcohol.

Written for “Senators Drug Policy Proposal” on 2026-11-22, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Senators Drug Policy Proposal
Politics · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
51
sentences that state something as happening or true
Uncertain
6%
3 of 51 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
67/100
Reason's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-22 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Reason · 1476 article(s) · 4 correction(s) detected
Running correction rate · 4 correction(s)

Who wrote this

Jeffrey A. Singer
5 article(s) here · 1 carrying a prediction
Under the proposal, Schedule I controls would apply to solid products containing more than 0.1 percent 7-OH or MP by weight, counting both together if a product contains both.
His Public Health and Research Reforms in Controlled Substances Act of 2026 would substantially overhaul federal drug scheduling, shift key decisions from law enforcement to health officials, ease research restrictions, deschedule marijuana, and reduce mandatory prison penalties.
Patients diagnosed with progressive dementia may know exactly how much deterioration they are willing to endure.
Depending on the employer's plan, patients who choose a Garner-recommended doctor may get reimbursed for some or all of their copays, coinsurance, or deductible expenses.
Anyone born after January 1, 2006, will never be old enough to legally buy nicotine products there.
Also by Jeffrey A. Singer
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

DEA Reason Reason Foundation Schedule I the Drug Enforcement Administration

Subjects

DEA ORG · 10× FDA ORG · 2× Charles Grassley PERSON · 1× Department of Health and Human Services ORG · 1× Iowa GPE · 1× Reason ORG · 1× Reason Foundation ORG · 1× the Drug Enforcement Administration ORG · 1× the Food and Drug Administration ORG · 1× the United States GPE · 1×

Narrative

In their November 16 letter to the DEA and the Food and Drug Administration (FDA), Sen. Charles Grassley (R–Iowa) and seven colleagues said the DEA had doubled the previously allowable concentration of 7-OH and removed MP from Schedule I.
framing: assertive · carried by 1 article(s) · first seen 2026-11-22
Under the proposal, Schedule I controls would apply to solid products containing more than 0.1 percent 7-OH or MP by weight, counting both together if a product contains both.
2026-11-22 · Reason
Senators Want To Tell the Drug Police How To Practice Medicine · assertive framing

Claims (51 extracted, 3 hedged)

Eight senators want the Drug Enforcement Administration (DEA) to revive a limit it proposed but never imposed and ban a drug it already bans. asserted
it → want → drug
Their letter urges the agency to undo changes it has only proposed. asserted
it → urge → changes
"Kratom is an opioid," the senators begin. asserted
senators → begin → ?
Some compounds in kratom activate the same receptor as morphine. asserted
compounds → activate → morphine
But that doesn't mean all kratom products are alike. asserted
products → mean → ?
Kratom leaves contain trace amounts of 7-hydroxymitragynine (7-OH), but a cup of kratom tea and a tablet containing concentrated 7-OH can deliver very different amounts of the compound. asserted
cup → contain → compound
The senators' label glosses over a difference that matters when the government decides what to ban. asserted
government → gloss → what
A new review from Reason Foundation, the nonprofit that publishes Reason, describes how people have long used kratom to manage pain and ease opioid withdrawal. asserted
people → publish → withdrawal
In a survey, users reported taking kratom for anxiety, for pain while trying to avoid conventional opioids, or to cut back on or stop taking other opioids. asserted
users → report → opioids
In a letter to the Department of Health and Human Services, nine military veterans described using concentrated 7-OH to manage pain and symptoms of post-traumatic stress disorder and to move away from other opioids or alcohol. asserted
veterans → describe → opioids
These accounts tell us why people seek out these products. asserted
people → tell → products
Whether the products reliably help them remains a question for researchers. asserted
help → help → researchers
In July, the DEA proposed putting 7-OH in Schedule I, a federal classification that generally makes possession a crime, if the compound makes up more than 0.05 percent of a product by weight. asserted
compound → propose → weight
That proposal never took effect. asserted
proposal → take → effect
In August, the agency issued an order putting a related compound, mitragynine pseudoindoxyl (MP), in Schedule I regardless of its concentration. asserted
agency → issue → concentration
On October 14, the DEA proposed new limits. asserted
DEA → propose → limits
Under the proposal, Schedule I controls would apply to solid products containing more than 0.1 percent 7-OH or MP by weight, counting both together if a product contains both. asserted
product → apply → both
The proposal sets a separate concentration limit for liquids. asserted
proposal → set → liquids
It also requires at least 100 parts mitragynine, the main active compound in natural kratom, for every part of 7-OH and MP combined. asserted
It → require → OH
A product could fall below the concentration limit and still trigger Schedule I controls if it failed that second test. uncertain
it → fall → test
The DEA said it would publish an order on or after November 13. asserted
it → say → November
That was the earliest date the agency could publish the order. uncertain
agency → publish → order
The limits did not take effect automatically on that date, and the October notice left the August order on MP in place. asserted
notice → take → place
As of November 19, the DEA had yet to publish an order putting the new limits into effect. asserted
DEA → have → effect
In their November 16 letter to the DEA and the Food and Drug Administration (FDA), Sen. Charles Grassley (R–Iowa) and seven colleagues said the DEA had doubled the previously allowable concentration of 7-OH and removed MP from Schedule I. asserted
DEA → say → MP
The senators got the arithmetic right for solids: 0.1 percent is twice 0.05 percent. asserted
percent → get → solids
But the July and October figures both came from proposals. asserted
figures → come → proposals
And the October proposal would keep MP under Schedule I controls in products that exceed either threshold. asserted
that → keep → threshold
Asking the FDA to explain why health officials recommended a higher cutoff is reasonable. asserted
officials → ask → cutoff
Demanding that the DEA restore a ban it hasn't lifted is something else. asserted
it → demand → ban
A concentration limit tells us surprisingly little about the dose someone takes. asserted
someone → tell → dose
Two tablets of different sizes can contain the same amount of 7-OH, even if one crosses the concentration limit and the other falls below it. asserted
other → contain → it
The DEA acknowledges that controlled human trials have yet to establish safe consumption limits for concentrated 7-OH. asserted
trials → acknowledge → OH
What evidence shows that the senators' preferred cutoff would make consumers safer? asserted
consumers → show → ?
What evidence would justify prosecuting adults for possessing a product that crosses it? asserted
that → justify → it
Federal law reserves Schedule I for substances deemed to have a "high potential for abuse" and "no currently accepted medical use in treatment in the United States," among other criteria. asserted
law → reserve → criteria
Congress also gave the DEA power to place substances there temporarily when the agency finds an imminent hazard to public safety. asserted
agency → give → safety
Health officials supplied the proposed thresholds in this case. asserted
officials → supply → case
The DEA decides whether to impose them. asserted
DEA → decide → them
Federal drug police already decide what adults can take to manage pain or cope with withdrawal. asserted
adults → decide → withdrawal
…and 11 more, not listed.
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support